2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

J Steffel, R Collins, M Antz, P Cornu, L Desteghe… - EP …, 2021 - academic.oup.com
1Department of Cardiology, Division of Electrophysiology, University Heart Center Zurich,
Switzerland; 2Age-Related Health Care, Tallaght University Hospital/Department of …

[HTML][HTML] Viscoelastic hemostatic assays: a primer on legacy and new generation devices

O Volod, CM Bunch, N Zackariya, EE Moore… - Journal of Clinical …, 2022 - mdpi.com
Viscoelastic hemostatic assay (VHAs) are whole blood point-of-care tests that have become
an essential method for assaying hemostatic competence in liver transplantation, cardiac …

[PDF][PDF] STS/SCA/AmSECT/SABM update to the clinical practice guidelines on patient blood management

P Tibi, RS McClure, J Huang, RA Baker… - The Journal of …, 2021 - ject.edpsciences.org
Owing to the constantly evolving nature of the medical literature, the Society of Thoracic
Surgeons (STS) clinical practice guidelines periodically undergoes evaluation and updating …

Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline

JD Douketis, AC Spyropoulos, MH Murad, JI Arcelus… - Chest, 2022 - Elsevier
Background The American College of Chest Physicians Clinical Practice Guideline on the
Perioperative Management of Antithrombotic Therapy addresses 43 Patients-Interventions …

[HTML][HTML] Direct oral anticoagulant plasma levels' striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona …

S Testa, P Prandoni, O Paoletti, R Morandini… - Journal of Thrombosis …, 2020 - Elsevier
Background Antiviral drugs are administered in patients with severe COVID‐19 respiratory
syndrome, including those treated with direct oral anticoagulants (DOACs). Concomitant …

[HTML][HTML] Laboratory monitoring of direct oral anticoagulants (DOACs)

C Dunois - Biomedicines, 2021 - mdpi.com
The introduction of direct oral anticoagulants (DOACs), such as dabigatran, rivaroxaban,
apixaban, edoxaban, and betrixaban, provides safe and effective alternative to previous …

[HTML][HTML] Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants

S Testa, C Legnani, E Antonucci, O Paoletti… - Journal of Thrombosis …, 2019 - Elsevier
Essentials• Currently, DOACs are given at fixed doses and do not require laboratory
monitoring.• Direct oral anticoagulant‐specific measurements were performed at trough and …

[HTML][HTML] Pharmacogenomics of novel direct oral anticoagulants: newly identified genes and genetic variants

SH Kanuri, RP Kreutz - Journal of personalized medicine, 2019 - mdpi.com
Direct oral anticoagulants (DOAC) have shown an upward prescribing trend in recent years
due to favorable pharmacokinetics and pharmacodynamics without requirement for routine …

Safety of direct oral anticoagulants in patients with advanced liver disease

G Semmler, K Pomej, DJM Bauer, L Balcar… - Liver …, 2021 - Wiley Online Library
Abstract Background & Aims While direct oral anticoagulants (DOACs) are increasingly used
in patients with liver disease, safety data especially in advanced chronic liver disease …

How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying normal reference intervals and assessing APTT reagents …

EJ Favaloro, G Kershaw… - … in thrombosis and …, 2019 - thieme-connect.com
The activated partial thromboplastin time (APTT) assay is a very common coagulation test,
used for several reasons. The test is conventionally used for assessing the contact factor …